SN-001 / Kunming SINOWAY Natural Pharma - LARVOL DELTA

Kunming Sano Pharmaceutical Co., Ltd.'s drug application for clinical trial implicit license was accepted [Google translation] (jrj.com) - "On April 9, according to the official website of CDE, Kunming Sano Pharmaceutical Co., Ltd. jointly applied for the drug 'SN-001 Concentrated Lyophilized Powder for Infusion' and received implicit permission for clinical trials, with the acceptance number CXSL2400077....Public information shows that the indications of the drug 'SN-001 Concentrated Lyophilized Powder for Infusion' are: relapsed or refractory CD22-positive B-cell hematological malignancies."

New trial • Hematological Malignancies • Oncology